Prostate Cancer
"Androgen Deprivation Therapy for Asymptomatic Advanced Prostate Cancer in the Prostate Specific Antigen Era: A National Survey of Urologist Beliefs and Practices."
Published in Cancer Weekly, June 29th, 1998
According to the authors' abstract of an article published in Journal of Urology, "Purpose: The use of androgen deprivation for prostate cancer without symptomatic metastases to the skeleton is controversial. However, by 1995 the use of medical androgen deprivation by injection was the thirteenth largest category of physician reimbursement by Medicare. To what degree do urologist attitudes towards androgen deprivation account for this growth' Materials and Methods: A survey was mailed to 582 United States urologists practicing at least 20 hours per week in 1995 which asked about use of androgen deprivation therapy when prostate specific antigen (PSA) levels rise after...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-06-29)
More Articles from Cancer Weekly
- Conference Coverage (ASCO)
Alternative Medicine Used to Compliment Conventional Cancer Therapy - Conference Coverage (ASCO)
Adenovirus-Mediated Gene Therapy Tolerated by Brain Tumor Patients - Angiogenesis
Inhibitor Expanded Studies Initiated in Europe and U.S. - Therapies
Addition of TNP-470/minocycline to Paclitaxel and Carboplatin - Therapies
As and AAs are Not Good Candidates for Anti-Angiogenic Therapy - Biochemical Behavior
Role of Nitric Oxide in Angiogenesis and Tumor Progression - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
